Fisher & Paykel Healthcare specializes in the development of healthcare technologies, particularly in respiratory care and sleep apnea solutions. The company has been operating for over 50 years.

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

COM:FPHCARE

Fisher & Paykel Healthcare

Last Close

37.07

21/11 04:00

Market Cap

18.43B

Beta: -

Volume Today

340.75K

Avg: -

locale

market

industry

website

ipo date

peer of

competitor of

Metrics